论文部分内容阅读
目的探讨糖化血红蛋白检测对糖尿病微血管病变的评估价值。方法选取本院自2011年5月至2013年6月收治的45例糖尿病微血管病变患者作为观察组,同时选取48例无微血管病变糖尿病患者为参考组,比较观察两组患者的空腹血糖及糖化血红蛋白水平。结果观察组患者空腹血糖及糖化血红蛋白水平均明显高于参考组,P<0.05,差异有统计学意义。结论糖化血红蛋白检测能够准确判断糖尿病为血管病变的发生及进展,在糖尿病肾病患者疾病的预防、诊断及治疗中有着显著的临床价值。
Objective To investigate the value of glycosylated hemoglobin (HbA1c) in the assessment of diabetic microangiopathy. Methods Forty-five patients with diabetic microangiopathy who were treated in our hospital from May 2011 to June 2013 were selected as the observation group and 48 patients without microvascular disease were selected as the reference group. The fasting blood glucose and glycosylated hemoglobin Level. Results The fasting blood glucose and glycosylated hemoglobin in the observation group were significantly higher than those in the reference group, P <0.05, the difference was statistically significant. Conclusions HbA1c can accurately determine the occurrence and progression of diabetes mellitus as a vascular disease and has significant clinical value in the prevention, diagnosis and treatment of the disease of patients with diabetic nephropathy.